ADARx Pharmaceuticals (ADRX) IPO deck
ADARx Pharmaceuticals is a clinical-stage biotechnology company developing targeted siRNA therapies to address complement-mediated, cardiovascular, and genetic diseases.
ADARx Pharmaceuticals is a clinical-stage biotechnology company developing targeted siRNA therapies to address complement-mediated, cardiovascular, and genetic diseases.
%20IPO%20deck){kind=link}